VORSCHAU

PRESSETERMINE

AKTUELLES PRESSEFOTO



WETTER
Graz: bedeckt
24°
Innsbruck: Regen
22°
Linz: Regen
22°
Wien: bedeckt
20°
© wetter.net

Stadtname / PLZ

AKTIENKURSE
 
ADHOC
Do, 01.06.2023 16:00
Meldung drucken Artikel weiterleiten
pta20230601042
Holding announcement according to article 135 section 2 BörseG (ESMA 2015/1597)
Pressefach Pressefach

Marinomed Biotech AG: Release according to article 135 section 2 BörseG

Korneuburg (pta042/01.06.2023/16:00) - Release of Announcement according to article 135 section 2 BörseG

Notification of Major Holdings

1. Issuer:
Marinomed Biotech AG, Hovengasse 25, 2100 Korneuburg, Austria

2. Reason for notification:
Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation
Name: Abdulmohsen Al Sheikh

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3


5. Date on which threshold was crossed or reached
30.05.2023

6. Total positions

% of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed / reached 5.19 0.00 5.19 1,519,167
Position of previous notification 13.86 13.86

7. Notified details of the resulting situation

7.a. Voting rights attached to shares

ISIN code absolute direct (Sec 130 BörseG 2018) absolute indirect (Sec 133 BörseG 2018) in % direct (Sec 130 BörseG 2018) in % indirect (Sec 133 BörseG 2018)
ATMARINOMED6 78,845 0 5.19 0.00
Total: 78,845 5.19

7.b.1. Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018

Type of instrument Expiration Date Exercise Period Voting Rights Absolute Voting Rights in %
Total:

7.b.2 Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018

Type of instrument Expiration Date Exercise Period Physical /Cash Settlement Voting Rights Absolute Voting Rights in %
Total:

8. Information in relation to the person subject to the notification obligation

Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).

No. Name Directly controlled by No. Shares held directly (%) Financial/other instruments held directly (%) Total of both (%)

9. In case of proxy voting

Date of general meeting: N/A

10. Additional Information
Die Beteiligungsmeldung erfolgt aufgrund der Schwellenüberschreitung wegen dem Erwerb von 78.845 Aktien.

(Ende)

Aussender: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Österreich
Ansprechpartner: Pascal Schmidt, CFO
Tel.: +43 2262 90300
E-Mail:
Website: www.marinomed.com
ISIN(s): ATMARINOMED6 (share)
Börsen: official trade in Vienna
Marinomed Biotech AG
   
So wurde bewertet:
Weitersagen
Share Share |
Social Media
ETARGET

FOCUSTHEMA


SPECIALS


Werbung
middleAdvertising